GSK insider Waterhouse to head drugmaker’s HIV unit ViiV

News Hour:

GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker’s majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah Waterhouse.

Waterhouse, currently in charge of primary care within GSK’s U.S. pharmaceuticals operation, will take over as ViiV chief executive at the same time as Emma Walmsley takes the helm of the wider GSK group, reports Reuters.

Limet has led ViiV for the past seven years. In recent times sales have grown strongly on the back of new HIV medicines. Pfizer and Shionogi are minority shareholders in ViiV.


This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Join Epidemiology Congress 2019

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts


News of the Month

Scroll Up
%d bloggers like this: